Abstract red lights with an overlaid line chart

Independent DMC Support and Interim Analysis for an ALS Clinical Trial 

1 minute read

Published: November 16th, 2026

Data Monitoring Committees play a vital role in safeguarding patient safety and supporting informed decision-making throughout clinical development, particularly in rare disease studies where every data point matters. 

In this ALS clinical trial, Phastar provided independent statistical support for four periodic safety reviews and a formal interim analysis, delivering validated outputs, secure reporting processes, and experienced DMC leadership. 

Through careful management of blinded and unblinded activities, robust statistical programming, and responsive support for emerging safety questions, the team helped ensure effective trial oversight and reliable decision-making. 

Download the full case study to see how Phastar supports safety monitoring, interim analyses, and independent data review in rare disease clinical trials. 

Related articles

From Rescue Study to Strategic Partnership: Accelerating Regulatory Submission Through Reliable Statistical Delivery

From Rescue Study to Strategic Partnership: Accelerating Regulatory Submission Through Reliable Statistical Delivery

November 16th, 2026 1 minute read

When clinical development programs face quality concerns, resource shortages, or submission risks, sponsors need a pa...

Turning a Failed Bioequivalence Study into a Successful Regulatory Outcome 

Turning a Failed Bioequivalence Study into a Successful Regulatory Outcome 

November 16th, 2026 1 minute read

When a bioequivalence study fails to meet regulatory criteria, understanding why is critical for successful developme...

Supporting a Global HIV Development Program Through Independent IDMC Oversight and Statistical Leadership

Supporting a Global HIV Development Program Through Independent IDMC Oversight and Statistical Leadership

November 16th, 2026 1 minute read

As clinical development programmes grow in scale and complexity, sponsors need confidence that safety and efficacy re...